TRIM73
gene geneOn this page
Summary
TRIM73 (tripartite motif containing 73, HGNC:18162) is a protein-coding gene on chromosome 7q11.23, encoding Tripartite motif-containing protein 73 (Q86UV7).
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response. Located in cytosol.
Source: NCBI Gene 375593 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_198924
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18162 |
| Approved symbol | TRIM73 |
| Name | tripartite motif containing 73 |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000178809 |
| Ensembl biotype | protein_coding |
| OMIM | 612549 |
| Entrez | 375593 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000323819, ENST00000430211, ENST00000447409, ENST00000450434, ENST00000463766, ENST00000483979, ENST00000862514
RefSeq mRNA: 1 — MANE Select: NM_198924
NM_198924
CCDS: CCDS34665
Canonical transcript exons
ENST00000323819 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002438342 | 75403645 | 75403740 |
| ENSE00002439922 | 75395629 | 75395810 |
| ENSE00002507097 | 75398916 | 75399332 |
| ENSE00002514412 | 75404839 | 75405069 |
| ENSE00003573105 | 75405182 | 75405605 |
Expression profiles
Bgee: expression breadth ubiquitous, 132 present calls, max score 86.19.
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| fundus of stomach | UBERON:0001160 | 86.19 | gold quality |
| body of stomach | UBERON:0001161 | 86.13 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 84.16 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 83.79 | gold quality |
| cerebellar cortex | UBERON:0002129 | 83.69 | gold quality |
| cerebellum | UBERON:0002037 | 83.68 | gold quality |
| right uterine tube | UBERON:0001302 | 83.47 | gold quality |
| right testis | UBERON:0004534 | 83.34 | gold quality |
| left testis | UBERON:0004533 | 83.15 | gold quality |
| stomach | UBERON:0000945 | 83.11 | gold quality |
| mucosa of stomach | UBERON:0001199 | 82.56 | gold quality |
| testis | UBERON:0000473 | 81.90 | gold quality |
| body of pancreas | UBERON:0001150 | 78.96 | gold quality |
| left uterine tube | UBERON:0001303 | 78.76 | gold quality |
| endocervix | UBERON:0000458 | 77.97 | gold quality |
| left ovary | UBERON:0002119 | 76.97 | gold quality |
| right ovary | UBERON:0002118 | 76.88 | gold quality |
| body of uterus | UBERON:0009853 | 76.77 | gold quality |
| cortex of kidney | UBERON:0001225 | 76.60 | gold quality |
| tibial nerve | UBERON:0001323 | 76.49 | gold quality |
| right lobe of liver | UBERON:0001114 | 76.48 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 76.32 | gold quality |
| ovary | UBERON:0000992 | 75.94 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 75.92 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.87 | gold quality |
| spleen | UBERON:0002106 | 75.42 | gold quality |
| uterine cervix | UBERON:0000002 | 75.28 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 75.13 | gold quality |
| skin of leg | UBERON:0001511 | 75.00 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 75.00 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-111727 | no | 282.17 |
| E-GEOD-124858 | no | 10.70 |
| E-ANND-3 | no | 2.04 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting TRIM73, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-766-5P | 99.47 | 67.91 | 2225 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-484 | 98.16 | 66.92 | 1074 |
| HSA-MIR-6511B-5P | 97.98 | 65.64 | 823 |
| HSA-MIR-6811-5P | 97.98 | 64.96 | 848 |
| HSA-MIR-3137 | 97.26 | 66.78 | 761 |
| HSA-MIR-6858-3P | 96.37 | 64.41 | 771 |
Literature-anchored findings (GeneRIF, showing 1)
- Maps within the critical region of Williams-Beuren syndrome. (PMID:18398435)
Cross-species orthologs
0 orthologs
Paralogs (80): MID2 (ENSG00000080561), TRIM9 (ENSG00000100505), MID1 (ENSG00000101871), MEFV (ENSG00000103313), TRIM35 (ENSG00000104228), TRIM14 (ENSG00000106785), TRIM37 (ENSG00000108395), TRIM2 (ENSG00000109654), TRIM3 (ENSG00000110171), TRIM38 (ENSG00000112343), TRIM62 (ENSG00000116525), TRIM67 (ENSG00000119283), TRIM32 (ENSG00000119401), BSPRY (ENSG00000119411), TRIM25 (ENSG00000121060), TRIM6 (ENSG00000121236), TRIM24 (ENSG00000122779), TRIM51 (ENSG00000124900), TRIM28 (ENSG00000130726), TRIM21 (ENSG00000132109), TRIM5 (ENSG00000132256), TRIM22 (ENSG00000132274), TRIM47 (ENSG00000132481), TRIM45 (ENSG00000134253), TRIM29 (ENSG00000137699), TRIM54 (ENSG00000138100), PML (ENSG00000140464), TRIM65 (ENSG00000141569), TRIM43B (ENSG00000144010), TRIM43 (ENSG00000144015), TRIM7 (ENSG00000146054), TRIM41 (ENSG00000146063), TRIM50 (ENSG00000146755), TRIM4 (ENSG00000146833), TRIM55 (ENSG00000147573), TRIM48 (ENSG00000150244), TRIM36 (ENSG00000152503), TRIM11 (ENSG00000154370), TRIM74 (ENSG00000155428), TRIM42 (ENSG00000155890)
Protein
Protein identifiers
Tripartite motif-containing protein 73 — Q86UV7 (reviewed: Q86UV7)
Alternative names: Tripartite motif-containing protein 50B
All UniProt accessions (4): Q86UV7, C9JQH3, I3L0H3, J3KQW6
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the TRIM/RBCC family.
RefSeq proteins (1): NP_944606* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000315 | Znf_B-box | Domain |
| IPR001841 | Znf_RING | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR017907 | Znf_RING_CS | Conserved_site |
| IPR027370 | Znf-RING_euk | Domain |
| IPR050143 | TRIM/RBCC | Family |
Pfam: PF00643, PF13445
UniProt features (9 total): binding site 4, zinc finger region 2, coiled-coil region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86UV7-F1 | 88.56 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 89; 92; 111; 117
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 26 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN, chr7q11, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, ZWANG_EGF_INTERVAL_UP, SRC_UP.V1_DN, PAF1_TARGET_GENES, GSE12366_GC_VS_MEMORY_BCELL_DN, MIR6811_5P, MIR6511B_5P, MIR3137, KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MO_UP
GO Biological Process (1): innate immune response (GO:0045087)
GO Molecular Function (3): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), metal ion binding (GO:0046872)
GO Cellular Component (2): cytoplasm (GO:0005737), cytosol (GO:0005829)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| immune response | 1 |
| defense response to symbiont | 1 |
| transition metal ion binding | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| cation binding | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
342 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TRIM73 | BBOX1 | O75936 | 777 |
| TRIM73 | ALKAL1 | Q6UXT8 | 540 |
| TRIM73 | TRIM56 | Q9BRZ2 | 459 |
| TRIM73 | TRIM52 | Q96A61 | 435 |
| TRIM73 | F5GXT2 | F5GXT2 | 431 |
| TRIM73 | FAM86C1P | Q9NVL1 | 419 |
| TRIM73 | TMEM270 | Q6UE05 | 418 |
| TRIM73 | TRIM40 | Q6P9F5 | 418 |
| TRIM73 | RNF113B | Q8IZP6 | 417 |
| TRIM73 | SPANXN5 | Q5MJ07 | 404 |
| TRIM73 | RNF207 | Q6ZRF8 | 382 |
| TRIM73 | LRRC41 | Q15345 | 377 |
| TRIM73 | TRIM3 | O75382 | 372 |
| TRIM73 | RFPL4A | A6NLU0 | 357 |
| TRIM73 | TRIML1 | Q8N9V2 | 357 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM73 | HSP90AB1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ECE1 | TRIM73 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (21): TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid), TRIM73 (Two-hybrid)
ESM2 similar proteins: A0JPQ4, E1BD59, O15197, P0C0K6, P62603, Q14142, Q1XH17, Q1XH18, Q3UWZ0, Q5BK82, Q5JZY3, Q5M929, Q5NCC3, Q5RBG2, Q5RKG6, Q5TM55, Q5W0U4, Q640S6, Q6P6S3, Q6PGR9, Q6PJ69, Q6ZMU5, Q7TPM3, Q7YR32, Q80VI1, Q80X56, Q80YW5, Q810I1, Q810I2, Q865W2, Q86UV6, Q86UV7, Q86XT4, Q8BFW4, Q8BVW3, Q8BYG9, Q8C006, Q8C0E3, Q8IUD6, Q8K243
Diamond homologs: A0A3B3IT33, A0JN74, A4QPC6, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, A6NLU0, B1H278, B6VQ60, C9J1S8, D4ABM4, F6ZQ54, F8VTS6, I1YAP6, O00478, O00481, O15344, O70583, O75677, O75678, O75679, O76064, P0CI25, P0CI26, P18892, P19474, P82458, P86448, P86449, Q02398, Q03605, Q13410, Q14258, Q1L5Z9, Q1XHT8, Q2HJ46, Q2T9Z0, Q3TL54
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | TRIM73 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 4 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1641 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:75399228:T:C | F99L | 0.977 |
| 7:75399230:C:A | F99L | 0.977 |
| 7:75399230:C:G | F99L | 0.977 |
| 7:75404878:T:C | F179L | 0.957 |
| 7:75404880:C:A | F179L | 0.957 |
| 7:75404880:C:G | F179L | 0.957 |
| 7:75405061:T:C | F240L | 0.953 |
| 7:75405063:C:A | F240L | 0.953 |
| 7:75405063:C:G | F240L | 0.953 |
| 7:75405185:T:C | F244L | 0.940 |
| 7:75405187:C:A | F244L | 0.940 |
| 7:75405187:C:G | F244L | 0.940 |
| 7:75399000:T:C | F23L | 0.906 |
| 7:75399002:C:A | F23L | 0.906 |
| 7:75399002:C:G | F23L | 0.906 |
| 7:75403727:G:C | R161P | 0.897 |
| 7:75399255:T:C | C108R | 0.884 |
| 7:75399209:C:A | H92Q | 0.878 |
| 7:75399209:C:G | H92Q | 0.878 |
| 7:75399229:T:C | F99S | 0.871 |
| 7:75399293:C:A | H120Q | 0.863 |
| 7:75399293:C:G | H120Q | 0.863 |
| 7:75403733:G:C | R163P | 0.859 |
| 7:75399332:G:C | K133N | 0.858 |
| 7:75399332:G:T | K133N | 0.858 |
| 7:75399264:T:A | C111S | 0.856 |
| 7:75399265:G:C | C111S | 0.856 |
| 7:75399256:G:A | C108Y | 0.853 |
| 7:75399284:C:A | H117Q | 0.851 |
| 7:75399284:C:G | H117Q | 0.851 |
dbSNP variants (sampled 300 via entrez): RS111656303 (7:75402415 G>A,T), RS111923502 (7:75401667 T>C), RS112340704 (7:75399739 T>C), RS112493146 (7:75398245 T>C), RS112728736 (7:75396500 G>A), RS113249493 (7:75397849 A>C,G), RS113406400 (7:75398282 T>C), RS1156312055 (7:75396419 G>A,T), RS1156445621 (7:75401119 A>G), RS1156746632 (7:75405619 G>A), RS1156849793 (7:75402632 C>A,T), RS1157357336 (7:75394706 C>T), RS1157629921 (7:75395668 T>A), RS1158231926 (7:75397679 G>A,C), RS1158475184 (7:75396099 C>T)
Disease associations
OMIM: gene MIM:612549 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, increases methylation, affects cotreatment | 5 |
| p-Chloromercuribenzoic Acid | affects cotreatment, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| 3,4-dichloroaniline | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | increases expression, decreases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, increases expression, decreases expression | 1 |
| licochalcone B | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Diuron | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.